HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 1 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $736,715 | +12.6% | 6,368 | +0.1% | 0.01% | +16.7% |
Q2 2023 | $654,434 | -5.3% | 6,363 | +0.5% | 0.01% | -14.3% |
Q1 2023 | $691,294 | +72.4% | 6,334 | -2.3% | 0.01% | +40.0% |
Q3 2022 | $401,000 | -94.2% | 6,481 | -92.6% | 0.01% | -91.9% |
Q2 2022 | $6,940,000 | +47.4% | 87,018 | +94.5% | 0.06% | +72.2% |
Q1 2022 | $4,707,000 | -39.3% | 44,740 | -37.8% | 0.04% | -37.9% |
Q4 2021 | $7,749,000 | -38.1% | 71,914 | -37.0% | 0.06% | -27.5% |
Q3 2021 | $12,509,000 | +108.6% | 114,196 | +78.3% | 0.08% | +53.8% |
Q2 2021 | $5,996,000 | +10.3% | 64,040 | +8.5% | 0.05% | 0.0% |
Q1 2021 | $5,434,000 | +44.2% | 59,043 | +13.4% | 0.05% | +33.3% |
Q4 2020 | $3,768,000 | +383.7% | 52,056 | +419.3% | 0.04% | +290.0% |
Q3 2020 | $779,000 | +48.7% | 10,025 | +6.4% | 0.01% | +42.9% |
Q2 2020 | $524,000 | +87.8% | 9,424 | 0.0% | 0.01% | +40.0% |
Q1 2020 | $279,000 | -13.1% | 9,424 | +6.1% | 0.01% | 0.0% |
Q4 2019 | $321,000 | – | 8,879 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,462,634 | $175,978,000 | 7.18% |
SCOPIA CAPITAL MANAGEMENT LP | 4,221,585 | $114,954,000 | 6.73% |
JW Asset Management, LLC | 270,775 | $7,373,000 | 6.49% |
KOPP INVESTMENT ADVISORS LLC | 104,462 | $2,845,000 | 5.23% |
1492 Capital Management LLC | 171,621 | $4,673,000 | 4.56% |
Avoro Capital Advisors LLC | 4,000,000 | $108,920,000 | 4.54% |
Paulson & Co. | 8,170,700 | $222,488,000 | 4.46% |
Rhenman & Partners Asset Management AB | 1,025,000 | $27,911,000 | 3.50% |
Redwood Investments, LLC | 1,376,066 | $37,470,000 | 2.88% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 218,000 | $5,938,000 | 2.74% |